ACT Genomics lands funding
ACT Genomics, a DNA sequencing-based cancer solution provider, has raised an undisclosed amount of funding.
ACT Genomics, a DNA sequencing-based cancer solution provider, has raised an undisclosed amount of funding.
Copyright PEI Media
Not for publication, email or dissemination